At AlionLife, we are pioneering drug-free mental and physical well-being through C-tactile (CT) nerve activation therapy. Our primary target groups include early adopter health enthusiasts, professional athletes, B2B stakeholders in the sports and health sectors, and healthcare providers engaged in clinical research collaborations across various therapeutic areas.
Our CT activation therapy is based on decades of research into the CT mechanism of action, led by pioneering scientists Francis McGlone and Håkan Olausson, as well as ongoing studies on its health benefits. We also collaborate with physiotherapist Jussi Pellonpää. CT nerves play a key role in stress management (e.g., cortisol regulation) and are linked to neural mechanisms in the insular cortex, which influence the reward system through dopamine and oxytocin mediation. By leveraging this process, our therapy offers a new, natural approach to enhancing mental and physical well-being.
Designed for individuals of all ages, our optimized CT activation therapy promotes stress tolerance, concentration, well-being, mental resilience, and psychophysical balance.
Contact us for more information and exclusive collaboration opportunities!
Read our latest news from Here!
